Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in pediatric patients with genotypes 1-6 chronic HCV infection: part 1 of the Dora study [abstract 2379]

Jonas MM, Squires RH, Rhee S. Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in pediatric patients with genotypes 1-6 chronic HCV infection: part 1 of the Dora study [abstract 2379]. The Liver Meeting. San Francisco, CA; 2018.

Publication Type:

Conference Proceedings

Authors:

Jonas, MM; Squires, RH; Rhee, S

Source:

The Liver Meeting, San Francisco, CA (2018)

Cited On:

Export Citation:
RIS Format
Top